JMVPX
Price
$34.97
Change
-$0.55 (-1.55%)
Updated
Feb 21 closing price
Net Assets
13.09B
VMVAX
Price
$85.40
Change
-$0.97 (-1.12%)
Updated
Feb 21 closing price
Net Assets
30.89B
Ad is loading...

JMVPX vs VMVAX

Header iconJMVPX vs VMVAX Comparison
Open Charts JMVPX vs VMVAXBanner chart's image
JPMorgan Mid Cap Value R3
Price$34.97
Change-$0.55 (-1.55%)
VolumeN/A
Net Assets13.09B
Vanguard Mid-Cap Value Index Admiral
Price$85.40
Change-$0.97 (-1.12%)
VolumeN/A
Net Assets30.89B
JMVPX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMVPX vs. VMVAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVPX is a Hold and VMVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. JMVPX (13.1B). VMVAX pays higher dividends than JMVPX: VMVAX (2.14) vs JMVPX (0.89). JMVPX was incepted earlier than VMVAX: JMVPX (8 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. JMVPX (12.00). JMVPX has a lower initial minimum investment than VMVAX: JMVPX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 12.44 vs. JMVPX (0.21). VMVAX return over 5 years is better than : 38.46 vs. JMVPX (-6.20).
JMVPXVMVAXJMVPX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years13 years-
Gain YTD0.9241.92148%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.1B30.9B42%
Annual Yield % from dividends0.892.1442%
Returns for 1 year0.2112.442%
Returns for 3 years-7.7815.34-51%
Returns for 5 years-6.2038.46-16%
Returns for 10 yearsN/A81.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDI9.96-0.02
-0.20%
DoubleDown Interactive Co Ltd
MANU14.46-0.15
-1.03%
Manchester United PLC
SRPT106.28-2.13
-1.96%
Sarepta Therapeutics
FTK8.22-0.20
-2.38%
Flotek Industries
ARTL1.16-0.04
-3.33%
Artelo Biosciences